Your session is about to expire
← Back to Search
Active Treatment vs Expectant Management for Patent Ductus Arteriosus (PDA Trial)
PDA Trial Summary
This trial compares the effects of active treatment versus expectant management for a symptomatic patent ductus arteriosus (sPDA) in premature infants.
PDA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPDA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PDA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a known lung malformation.My baby is between 2 days and 3 weeks old.I have a heart condition from birth, not including ASD or VSD.I have heart or lung problems that affect my daily activities.My heart condition is classified as sPDA with a small or moderate size.You have a specific heart condition called sPDA, which can be seen on an echocardiogram.My baby was born between 22 and 28 weeks of pregnancy.
- Group 1: Active Treatment Group
- Group 2: Expectant Management Group
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Active Treatment Group been cleared by the FDA?
"There is some clinical evidence to support Active Treatment Group's efficacy, and it has undergone multiple rounds of testing to confirm its safety. Consequently, it received a score of 3."
Are people of a certain age group excluded from participating in this research?
"This trial is accepting people who are younger than 21 days old and have been 48 hours since their birth."
I am interested in enrolling in this research, who should I talk to?
"Currently, this study is looking for 1116 participants that were born with an infant, newborn, disease. The age bracket for participants is 48 Hours to 21 Days. To meet the requirements for this study, candidates must: Infant 22 0/7 to 28 6/7 weeks gestation at birth, Postnatal age 48 hours -21 days."
Share this study with friends
Copy Link
Messenger